mesothelioma epithelial
Wednesday, August 26th, 2009Clinical trials are used to determine whether the treatment is safe for general use and if it is really effective against disease. Participation in clinical trials is an important treatment option for many patients with mesothelioma in the currently used treatments offer little hope of a cure.
Mesothelioma is very resistant to medical treatment, and experts believe there may be an epidemic of mesothelioma cases in the coming years. Clinical trials (research studies with people) are designed to find new treatments and better ways to use current treatments, increased hope for victims of this disease devastating. These are three major ongoing clinical trials for treatment of mesothelioma.
1 trial Phase III vorinostat (SAHA) clinics for Progressive or relapse in patients with malignant pleural mesothelioma. This trial is studying the use of vorinostat chemotherapy drug to kill cancer cells and stop their division, also believes the drug can inhibit enzymes needed by cancer cells for growth and multiplication. These studies are currently in the third phase to understand its effects on epithelial, sarcomatous, and recurrent mesothelioma. Phase III vorinostat (SAHA), trials for patients with progressive or recurrent mesothelioma malignant pleural taking place in the Jonsson Comprehensive Cancer Center at UCLA and Warren Grant Magnuson Clinical Center – NCI Clinical Studies Support, Bethesda, Maryland.
2-Phase II clinical trial for AZD2171 in patients with unresectable malignant mesothelioma AZD2171 Phase II for patients with inoperable malignant mesothelioma is investigating the use of chemotherapy drugs to inhibit enzymes that inhibit growth and block the blood supply to cancer cells. Cancer cells depend on the formation of new blood vessels that carry blood to supply nutrients needed for growth, new drugs are being studied, which inhibit development of these new blood vessels. This paper attempts result in the development of drugs used to treat epithelial malignant mesothelioma, sarcomatous, advanced and recurrent. These clinical trials are underway in Arizona, Georgia, Illinois, Indiana, Iowa, Kansas, Massachusetts, Michigan, Missouri, Montana, North Carolina Ohio, South Carolina, Tennessee, Virginia, Washington, and Wyoming.
3-phase II clinical trials on the use of pemetrexed disodium with gemcitabine or carboplatin in patients with advanced malignant mesothelioma. The phase II clinical trials on the use of pemetrexed disodium with gemcitabine or carboplatin in patients with mesothelioma clinical advanced malignant is a study to examine the effects of the chemotherapy drugs pemetrexed disodium, gemcitabine and carboplatin on advanced and recurrent malignant mesothelioma. This study is in Phase II and is being conducted in various locations throughout the country, including Delaware, Florida, Illinois, Indiana, Iowa, Maryland, Michigan, New Jersey, New York, Ohio, Pennsylvania, South Dakota and Wisconsin.
The victims of mesothelioma should always try to ask your oncologist about clinical trials available in your area.
About the Author:
Bello Kamorudeen. For more information on mesothelioma clinical trials go to http://www.mesotheliomacorner.blogspot.com
Article Source: ArticlesBase.com – Mesothelioma Clinical Trial-An overview of three important clinical trials